Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
3Initial filing by director officer or owner of more than ten percent.Dec 23, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 6, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 6, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 6, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 6, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 2, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 2, 2004View HTMLDownload DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Aug 23, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 23, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 20, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 29, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 12, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 15, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 4, 2004View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4May 14, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 11, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 5, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 2, 2004View HTMLDownload DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Jan 27, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 27, 2004View HTMLDownload DOCDownload PDF
1-25      26-31

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information